Archives

Fundamental Picks (for more than a year) 1) L&T – Target – 4400 (21%) 2) Tata Consumer – Target – 1350 (20%) 3) ICICI Bank – Target – 1300 (16%) 4) Bharti Airtel- Target – 1640 (14%) 5) Polycab – Target- 7850 (12%) Technical Pick (for 2-3 days) IEX Previous Close – 174 Target – 185 Potential Upside – 6% Fundamental Picks (for more than a year) 1) L&T – Target – 4400 (21%) 2) Tata Consumer – Target – 1350 (20%) 3) ICICI Bank – Target – 1300 (16%) 4) Bharti Airtel- Target – 1640 (14%) 5) Polycab – Target- 7850 (12%) Technical Pick (for 2-3 days) IEX Previous Close – 174 Target – 185 Potential Upside – 6%

Fundamental Picks (for more than a year) 1) L&T – Target – 4400 (21%)2) Tata Consumer – Target – 1350 (20%)3) ICICI Bank – Target […]

Please follow and like us:

#FOMC kept rate unchanged and we have seen small recover in #DJI last night. After election we have all gapup is correcting in intraday and bank nifty is hovering in a narrow range of with in last week. Expecting a breakout either side. Nifty making new high and profit booking same day. 23420 and 50200 need to clear with positive approach for fresh breakout else ping pong in a range #FOMC kept rate unchanged and we have seen small recover in #DJI last night. After election we have all gapup is correcting in intraday and bank nifty is hovering in a narrow range of with in last week. Expecting a breakout either side. Nifty making new high and profit booking same day. 23420 and 50200 need to clear with positive approach for fresh breakout else ping pong in a range

#FOMC kept rate unchanged and we have seen small recover in #DJI last night. After election we have all gapup is correcting in intraday and […]

Please follow and like us:

Securities in Ban For Trade Date 13-JUN-2024:  1 BALRAMCHIN 2 GMRINFRA 3 HINDCOPPER 4 INDIACEM 5 SAIL #FinanceNews #WallStreet StockMarket Securities in Ban For Trade Date 13-JUN-2024:  1 BALRAMCHIN 2 GMRINFRA 3 HINDCOPPER 4 INDIACEM 5 SAIL #FinanceNews #WallStreet StockMarket

Securities in Ban For Trade Date 13-JUN-2024:  1 BALRAMCHIN 2 GMRINFRA 3 HINDCOPPER 4 INDIACEM 5 SAIL #FinanceNews #WallStreet StockMarket Securities in Ban For Trade […]

Please follow and like us:

Global Indices GIFT Nifty: 23453 +85 Hangseng: 18043 +106 Dow: 38712 – 35 S&P 500: 5421 +45 Nasdaq: 17610 +267 USD / INR: 83.50 Brent Crude: 82.25 GOLD: 2327 FII Net (12-06-2024):  +426.63 DII Net (12-06-2024):  +233.75 #StockMarket #FinanceNews # Malaysian #FinanceNews Global Indices GIFT Nifty: 23453 +85 Hangseng: 18043 +106 Dow: 38712 – 35 S&P 500: 5421 +45 Nasdaq: 17610 +267 USD / INR: 83.50 Brent Crude: 82.25 GOLD: 2327 FII Net (12-06-2024):  +426.63 DII Net (12-06-2024):  +233.75 #StockMarket #FinanceNews # Malaysian #FinanceNews

Global Indices GIFT Nifty: 23453 +85Hangseng: 18043 +106Dow: 38712 – 35S&P 500: 5421 +45Nasdaq: 17610 +267USD / INR: 83.50Brent Crude: 82.25GOLD: 2327FII Net (12-06-2024):  +426.63DII […]

Please follow and like us:

FOREIGN SEC SAYS PM Narenda Modi will be travelling tomorrow to Italy for 50th edition of G7 • This will be first foreign visit of PM Modi in his 3rd term • This is India’s 7th participation in G7 • G7 under Italian presidency has chosen some key priorities • Russia Ukraine conflict, Middle • East, relations with developing nations, Africa and Global South • Migration together with climate energy linkages as well as Al- NDTV PROFIT FOREIGN SEC SAYS PM Narenda Modi will be travelling tomorrow to Italy for 50th edition of G7 • This will be first foreign visit of PM Modi in his 3rd term • This is India’s 7th participation in G7 • G7 under Italian presidency has chosen some key priorities • Russia Ukraine conflict, Middle • East, relations with developing nations, Africa and Global South • Migration together with climate energy linkages as well as Al- NDTV PROFIT

FOREIGN SEC SAYS PM Narenda Modi will be travelling tomorrow to Italy for 50th edition of G7 • This will be first foreign visit of […]

Please follow and like us:

Dr. Reddys -USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. -Sales of the product for the past 12 months ended March 2024 were $51.8 million Dr. Reddys -USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. -Sales of the product for the past 12 months ended March 2024 were $51.8 million

Dr. Reddys -USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. -Sales of […]

Please follow and like us:

EXIDE INDUSTRIES: CO INVESTED ABOUT 750M RUPEES VIA SUBSCRIPTION IN SHARE CAPITAL OF UNIT || CO INVESTED VIA SUBSCRIPTION IN SHARE CAPITAL OF EXIDE ENERGY SOLUTIONS ON RIGHTS BASIS EXIDE INDUSTRIES: CO INVESTED ABOUT 750M RUPEES VIA SUBSCRIPTION IN SHARE CAPITAL OF UNIT || CO INVESTED VIA SUBSCRIPTION IN SHARE CAPITAL OF EXIDE ENERGY SOLUTIONS ON RIGHTS BASIS

EXIDE INDUSTRIES: CO INVESTED ABOUT 750M RUPEES VIA SUBSCRIPTION IN SHARE CAPITAL OF UNIT || CO INVESTED VIA SUBSCRIPTION IN SHARE CAPITAL OF EXIDE ENERGY […]

Please follow and like us: